Insecure Access Control in ZKTeco BioTime Leads to Data Exposure
CVE-2023-38952

7.5HIGH

Key Information:

Vendor

Zkteco

Status
Biotime
Vendor
CVE Published:
3 August 2023

What is CVE-2023-38952?

The ZKTeco BioTime v8.5.5 product suffers from an insecure access control flaw that permits unauthenticated attackers to leverage specially crafted HTTP requests. This vulnerability enables them to read sensitive backup files, potentially resulting in the exposure of user credentials and other critical system information. Organizations using this version of BioTime should assess their security measures to mitigate unauthorized access risks.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

References

http://zkteco.com
https://claroty.com/team82/disclosure-dashboard/cve-2023-...
https://github.com/omair2084/biotime-rce-8.5.5/blob/main/...

EPSS Score

16% chance of being exploited in the next 30 days.

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
None
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.